Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: PD-L2, PDL2, PDCD1LG2, PDCD1L2, CD273, PDCD1 ligand 2, Butyrophilin B7-DC, Btdc, bA574F11.2, B7DC
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 50 μL | $208 | 7-10 days | 7-10 days | |
| 100 μL | $347 | 7-10 days | 7-10 days |
| Description | Anti-PD-L2 Antibody (2N448) is a Mouse antibody targeting PD-L2. Anti-PD-L2 Antibody (2N448) can be used in ELISA,FCM,IF,IHC,IP,WB. |
| Synonyms | PD-L2, PDL2, PDCD1LG2, PDCD1L2, CD273, PDCD1 ligand 2, Butyrophilin B7-DC, Btdc, bA574F11.2, B7DC |
| Ig Type | IgG2b |
| Clone | 2N448 |
| Reactivity | Human |
| Application | |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Subcellular Localization | [Isoform 3]: Secreted.; [Isoform 2]: Endomembrane system; Single-pass type I membrane protein.; [Isoform 1]: Cell membrane; Single-pass type I membrane protein. |
| Tissue Specificity | Highly expressed in heart, placenta, pancreas, lung and liver and weakly expressed in spleen, lymph nodes and thymus. |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Protein A purified |
| Appearance | Liquid |
| Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
| Purity | >95% |
| Research Background | Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human Programmed cell death 1 ligand 2 Protein (21-118AA) |
| Antigen Species | Human |
| Gene Name | PDCD1LG2 |
| Gene ID | |
| Uniprot ID | |
| Biology Area | Immunology |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.